GlobalIPNews

Sign Up
|
Login
|

06:38:05 Fri 19 Jun 2026

Home
About Us
Industry
Assignee
Country
Support
Products
Services
View ALl

News For Last 1 Week

Industry

X

Assignee

X

Shanghai Jiao Tong Univer

(35)

Tianjin University

(31)

Hoffmann La Roche

(23)

Gilead Sciences

(15)

Jiangsu Hengrui Pharmaceu

(14)

Eli Lilly and Company

(13)

(11)

Chia Tai Tianqing Pharmac

(10)

Beijing Sun Novo Pharmace

(9)

(9)

Tianjin University of Sci

(9)

Haisco Pharmaceutical Gro

(8)

Shanghai Hansoh Biomedica

(8)

(7)

(7)

Regeneron Pharmaceuticals

(7)

Shanghai Qilu Pharmaceuti

(7)

Chugai Pharmaceutical

(6)

Deciphera Pharmaceuticals

(6)

Insilico Medicine

(6)

(6)

Shenzhen Salubris Pharmac

(6)

Xinjiang Xinziyuan Biolog

(6)

Changchun Genescience Pha

(5)

Guangdong Pharmaceutical

(5)

Hangzhou Zhongmei Huadong

(5)

Hunan Yineng Biological M

(5)

Innovent Biologics, Suzho

(5)

Jiangsu Hengrui Medicine;

(5)

LYNK Pharmaceuticals

(5)

Otsuka Pharmaceutical

(5)

Principia Biopharma

(5)

(5)

Shanghai Hansoh Biomedica

(5)

Taipei Medical University

(5)

Xizang Haisco Pharmaceuti

(5)

Zhejiang University

(5)

China Pharmaceutical Univ

(4)

Genzyme Corporation

(4)

Hisamitsu Pharmaceutical

(4)

(4)

Institute of Materia Medi

(4)

Janssen Pharmaceutica

(4)

Jewim Pharmaceutical (Sha

(4)

Kobayashi Pharmaceutical

(4)

ROHTO Pharmaceutical

(4)

Shaanxi Maikeaote Pharmac

(4)

The Second Xiangya Hospit

(4)

(4)

Vertex Pharmaceuticals

(4)

Ausa Pharmed Ltd; Aosa Ph

(3)

Beijing Fuyuan Pharmaceut

(3)

Boehringer Ingelheim Inte

(3)

Chongqing Academy of Chin

(3)

Chongqing Medical Univers

(3)

Dewpoint Therapeutics

(3)

Halda Therapeutics OpCo

(3)

Hangzhou Arteryflow Techn

(3)

Henan Univ Of Medicine

(3)

Huayi Pharmaceutical Guan

(3)

Hubei Gedian Humanwell Ph

(3)

(3)

I Care You Biotech Co Ltd

(3)

IDEAYA Biosciences

(3)

Institute Military Medici

(3)

(3)

Kissei Pharmaceutical

(3)

Kojin Therapeutics

(3)

Lunan Pharmaceutical Grou

(3)

Mediar Therapeutics Inc

(3)

Meilan Hangzhou Pharmaceu

(3)

(3)

Revolution Medicines

(3)

Ruijin Hospital Shanghai

(3)

Shanghai East Hospital To

(3)

Shanghai Sandy Biopharmac

(3)

Vifor International

(3)

Vigil Neuroscience

(3)

Academy of Military Medic

(2)

Achieve Life Sciences Inc

(2)

Agios Pharmaceuticals

(2)

Alnylam Pharmaceuticals

(2)

Americana Pharma Llc

(2)

Anivance Ai Corp

(2)

(2)

Ascendis Pharma

(2)

Averna Therapeutics Ltd

(2)

Beijing Innocare Pharma T

(2)

Beijing Lande Wanbang Pha

(2)

Beijing Puqi Pharmaceutic

(2)

Beijing Risuntechnology C

(2)

Beijing Tide Pharmaceutic

(2)

Bide Pharmatech Co Ltd

(2)

(2)

BlueRock Therapeutics

(2)

Boehringer Ingelheim Int

(2)

Bohui Biopharmaceutical Y

(2)

Botong Medical Tech Beiji

(2)

Caliway Biopharmaceutical

(2)

Cancer Hospital, CAMS

(2)

(2)

Changchun Sinobiomaterial

(2)

Changsha Stem Cell And Re

(2)

Changzhou University

(2)

Chengdu Kanghong Pharmace

(2)

Chia Nan University of Ph

(2)

Chiesi Farmaceutici

(2)

China Japan Friendship Ho

(2)

Chong Kun Dang Pharmaceut

(2)

Constant Therapeutics Llc

(2)

Daewoong Pharmaceutical

(2)

(2)

Daiichi Sankyo Healthcare

(2)

Debiopharm International

(2)

Delphia Therapeutics Inc

(2)

Denali Therapeutics

(2)

(2)

Design Therapeutics

(2)

Dianthus Therapeutics

(2)

Dyno Therapeutics

(2)

(2)

(2)

First Affiliated Hospital

(2)

First Affiliated Hospital

(2)

Fudan University

(2)

Green Carbon Forever Tech

(2)

Guangdong Raynovent Biote

(2)

Hangzhou Baicreat Pharma

(2)

Hangzhou Grand Biological

(2)

Hangzhou Hospital of Trad

(2)

Hangzhou Zhongmei Huadong

(2)

Hanmi Pharmaceutical

(2)

Hebei Wanbang Folon Pharm

(2)

Heyling Pharmaceutical Gu

(2)

Huazhong Pharmaceutical C

(2)

Huazhong University of Sc

(2)

Hubei Huahai Gongtong Pha

(2)

Iambic Therapeutics

(2)

Ionis Pharmaceuticals

(2)

JW Pharmaceutical

(2)

Jewim Pharmaceutical Rese

(2)

Jiangsu Hengrui Medicine;

(2)

Jiangsu Hengrui Pharmaceu

(2)

Jiangsu Hi Stone Pharmace

(2)

Jiangsu Ocean University

(2)

Jiangsu Zhiyuan Pharmaceu

(2)

Jiaxing Baimei Jihua Phar

(2)

(2)

Jinghua Pharmaceutical Gr

(2)

Johnson & Johnson Enterpr

(2)

Kamp Pharmaceutical

(2)

Kunming Medical Universit

(2)

Kunming University of Sci

(2)

Lanzhou University

(2)

Lilum Therapeutics Inc

(2)

Morphic Therapeutic

(2)

Muna Therapeutics

(2)

Nanjing Chia-Tai Tianqing

(2)

Nanjing University of Chi

(2)

Nanjing Zeheng Pharmaceut

(2)

National Univ Hospital Si

(2)

Ningxia Zhouyang Pharmace

(2)

Nona Biosciences Suzhou

(2)

Otsuka Pharma Co Ltd [jp]

(2)

Pasithea Therapeutics Cor

(2)

(2)

Pharmaengine Inc

(2)

(2)

Qidong Dongyue Pharmaceut

(2)

Qihe Frontier Biological

(2)

Qingdao University

(2)

Qinghai University for Na

(2)

(2)

Renibus Therapeutics

(2)

Rigel Pharmaceuticals

(2)

Santen Pharmaceutical

(2)

Servier Lab [fr]; Novarti

(2)

Shaanxi University of Sci

(2)

Shandong Suncadia Medicin

(2)

Shanghai Aobo Bio Pharmac

(2)

Shanghai Apeiron Therapeu

(2)

Shanghai Argo Biopharmace

(2)

Shanghai Aryl Pharmtech C

(2)

Shanghai Hansoh Biomedica

(2)

Shanghai Syncores Tech In

(2)

Shanghai University of Tr

(2)

Shenyang Pharmaceutical U

(2)

Shenzhen Second People\'s

(2)

Shijiazhuang No 4 Pharmac

(2)

Sichuan Kelun-Biotech Bio

(2)

Sichuan University

(2)

Simcere Pharmaceutical Co

(2)

Simcere Remediation Pharm

(2)

Sinocaber Pharmaceutical

(2)

Sinovet Jiangsu Biopharma

(2)

Souffle Therapeutics Inc

(2)

Sun Yat-sen University

(2)

Suntory Holdings

(2)

(2)

The Third Xiangya Hospita

(2)

Tianjin Polytechnic Unive

(2)

Tianjin University of Tra

(2)

Tianjin University; Verta

(2)

Tuojie Biotech (Shanghai)

(2)

Tyra Biosciences

(2)

Univ Houston System [us];

(2)

University Jining Medical

(2)

University Liaoning Tradi

(2)

University Yunnan Traditi

(2)

Veradermics Incorporated

(2)

West China 2nd University

(2)

West China Hospital, Sich

(2)

Wigen Biomedicine Technol

(2)

(2)

Wuxi Zishan Pharmaceutica

(2)

Ya Therapeutics Inc

(2)

Yichang Humanwell Pharmac

(2)

Yueyang Hospital of Integ

(2)

(2)

Zhejiang Fresh Pharmaceut

(2)

Zhejiang Nuode Pharmaceut

(2)

Zhejiang University of Te

(2)

Zhuhai Beihai Biotech

(2)

Zydus Lifesciences

(2)

3dmed Biomedical Shanghai

(1)

3h Pharmaceuticals Co Ltd

(1)

4e Therapeutics

(1)

9163 0384 Quebec Inc

(1)

9494 1861 Quebec Inc

(1)

A2a Pharmaceuticals Inc

(1)

(1)

Ablynx Nv [be]; Sanofi

(1)

Aconcagua Bio Inc

(1)

Acurex Biosciences Corp

(1)

Adcentrx Therapeutics Inc

(1)

Adlai Nortye Biopharma

(1)

Adlai Nortye Biopharma Co

(1)

Adsentex Therapeutics Inc

(1)

Affiliated Hospital Of In

(1)

Affiliated Hospital of Na

(1)

Affiliated Hospital of So

(1)

Affini T Therapeutics Inc

(1)

Agna Biopharmaceuticals I

(1)

Ahersla Health Inc [us];

(1)

Aibeile Pharmaceutical Te

(1)

Aikeruiran Hong Kong Indu

(1)

Aileens Pharma S R L

(1)

Aiweituo Jiangsu Pharmace

(1)

Aiweituo Jiangsu Pharmace

(1)

(1)

Alebund Pharmaceuticals H

(1)

Alexion Pharmaceuticals

(1)

Allergan Pharmaceuticals

(1)

Alnylam Pharmaceuticals I

(1)

Alnylam Pharmaceuticals I

(1)

Alpha Cognition

(1)

(1)

Amgen Research (Munich)

(1)

Amicus Therapeutics

(1)

Amunix Pharmaceuticals In

(1)

(1)

Anburui Fujian Pharmaceut

(1)

Angel Enzyme Yichang Co L

(1)

Anhui Double Crane Pharma

(1)

Anhui Haikang Pharmaceuti

(1)

Anhui Teyi Kangyang Biote

(1)

Anhui University of Chine

(1)

Anhui Yipuke Medical Tech

(1)

Anhui Zhongke Tuoran Phar

(1)

(1)

(1)

Annji Pharm Co Ltd

(1)

Anomed Singapore Pte Ltd;

(1)

Antengene Biologics Ltd

(1)

Antharis Therapeutics Inc

(1)

Antiva Biosciences

(1)

Anxo Pharmaceutical

(1)

Anyong Biotechnology Inc

(1)

Aobio Pharmaceutical Co L

(1)

Aosa Pharmed Ltd

(1)

Aozhilin Beijing Biotechn

(1)

Apellis Pharmaceuticals

(1)

Apex Laboratories Private

(1)

Apogee Biotechnology Corp

(1)

Apogee Therapeutics Inc

(1)

Apollo Ap43 Ltd

(1)

Apon Zhiyuan Brain Scienc

(1)

Applied Pharmaceutical Sc

(1)

Apramitha Innovations Pri

(1)

Arentis Therapeutics Ag

(1)

Ares Trading Sa

(1)

Arite Pharmaceutical Co L

(1)

Arizest Shanghai Pharmace

(1)

Arog Pharmaceuticals

(1)

Arvinas Operations

(1)

Arvinas Operations Inc [u

(1)

Ascendis Pharma Bone Dise

(1)

(1)

Asia Pacific Global Pharm

(1)

Asocura Pharmaceuticals S

(1)

Assembly Biosciences

(1)

Astatech Chengdu Biopharm

(1)

Astatech Chengdu Biopharm

(1)

Astellas Gene Therapies

(1)

AstraZeneca Ireland

(1)

Astrid Pharma Corp

(1)

Athena Pharmaceutiques Sa

(1)

Ativa Biomedical Corp

(1)

Atom High Technology

(1)

Atossa Therapeutics

(1)

Ausa Pharmed Ltd; Shandon

(1)

Ausa Pharmed Ltd; Shenzhe

(1)

Autobio Experimental Inst

(1)

Avidity Biosciences Llc

(1)

Axsome Therapeutics

(1)

Axter Therapeutics Beijin

(1)

(1)

Azurity Pharmaceuticals I

(1)

Azvlz Pharma Inc

(1)

Baichuan Tiancheng Shaanx

(1)

Bala Therapeutics

(1)

Bashanhong Beijing Pharma

(1)

Basilea Pharmaceutica Int

(1)

BeiGene Switzerland

(1)

Beijing Beimei Pharmaceut

(1)

Beijing Biote Pharmaceuti

(1)

Beijing Caomu Liangfang C

(1)

Beijing Chaoyang Hospital

(1)

Beijing Chest Hospital Ca

(1)

Beijing Children\'s Hospi

(1)

Beijing City University

(1)

Beijing Friendship Hospit

(1)

Beijing Guohua Xinye Trad

(1)

Beijing Hengtaikang Pharm

(1)

Beijing Hongjiu Life Scie

(1)

Beijing Huaxiabaicao Heal

(1)

Beijing Jitai Pharmaceuti

(1)

Beijing Junda High Tech M

(1)

Beijing Jutai Biotechnolo

(1)

Beijing Kangchuanglian Bi

(1)

Beijing Kangerfu Pharmace

(1)

Beijing Kawin Technology

(1)

Beijing Liyan Siyan Biote

(1)

Beijing Puer Weiye Biolog

(1)

Beijing Qingyan Boshi Hea

(1)

Beijing Quantum Hi Tech P

(1)

Beijing Sunho Pharmaceuti

(1)

Beijing University of Chi

(1)

Beijing University; Beiji

(1)

Beijing Winsunny Pharmace

(1)

Beijing Xinghaoyingsheng

(1)

Belgrade Abella Pharma In

(1)

Bell Polyester Products I

(1)

Bell Therapeutics

(1)

Bencaofangtang Traditiona

(1)

(1)

(1)

Betta Pharmaceuticals

(1)

Biaoxin Biomedical Tech S

(1)

Binzhou Medical College

(1)

(1)

BioMarin Pharmaceutical

(1)

(1)

Bioasia Pharmaceutical Co

(1)

Biocad Joint Stock

(1)

Biohaven Therapeutics

(1)

(1)

Biotech Pharmaceuticals C

(1)

Biotheus Hengqin Co Ltd

(1)

Bloomage Biotechnology Co

(1)

BlossomHill Therapeutics

(1)

Blueprint Medicines

(1)

Boce Biomedical Tianjin C

(1)

Boehringer Ingelheim Vetm

(1)

(1)

Borea Therapeutics S R L

(1)

Boson Biotech Co Ltd

(1)

Bozhou Qianhe Pharmaceuti

(1)

C&c Res Lab [kr]; JW Phar

(1)

Caliway Biomedical Co Ltd

(1)

Calliditas Therapeutics

(1)

Cancer Research Tech Ltd

(1)

Cangzhou Inst Of Technolo

(1)

Canupemmune Therapeutics

(1)

Capital University of Med

(1)

Cardiolink Shenzhen Medic

(1)

Cardurion Pharmaceuticals

(1)

Carmot Therapeutics

(1)

Carnos Therapeutics Inc

(1)

Catholic Univ Industry Ac

(1)

(1)

Celgene Corp [us]; Pfizer

(1)

(1)

Celltrion Inc [kr]; Pinot

(1)

Centre For Immunology & I

(1)

Cg Pharmaceuticals Inc

(1)

Chang Gung University of

(1)

Changchun Institute of Ap

(1)

Changchun University of C

(1)

Changshan Conjuchem Bioph

(1)

Changshu Lei Yun Shang Ph

(1)

Chase Therapeutics

(1)

Chemyunion Ltda

(1)

(1)

(1)

(1)

Chengde Water Conservancy

(1)

Chengdu Chipscreen Pharma

(1)

Chengdu First Pharmaceuti

(1)

Chengdu Gowell Bio Pharma

(1)

Chengdu Institute Biology

(1)

Chengdu Kuachangaopu Medi

(1)

Chengdu Qingshan Likang P

(1)

Chengdu Renqing Yishou Ph

(1)

Chengdu Saijing Biopharma

(1)

Chengdu Shibeikang Biomed

(1)

Chengdu Tailibei Pharmace

(1)

Chengdu Yazhong Bio Pharm

(1)

Chengtu Intelligent Tech

(1)

China Academy of Chinese

(1)

China Electric Power Rese

(1)

China Institute for Radia

(1)

China Nat Offshore Oil Co

(1)

China Pharmaceutical Univ

(1)

China Pharmaceutical Univ

(1)

China Resources Sanjiu Ta

(1)

China State Inst Of Pharm

(1)

Chongqing Apu Gelei Biote

(1)

Chongqing Huasen Yingnuo

(1)

Chongqing Shiquan Ecologi

(1)

Chongqing Univ Of Chinese

(1)

Chongqing Xinongdakexin A

(1)

Chunan First People\'s Ho

(1)

Chung Shan Medical Univ H

(1)

Chupu Chuangzhi Wuhan Pha

(1)

Cie Laitiere Europeenne

(1)

Cinclus Pharma Holding AB

(1)

Cisen Pharmaceutical Co L

(1)

Clearmy Labs Inc

(1)

Click Therapeutics

(1)

Colgate-Palmolive

(1)

Concept To Medicine Biote

(1)

Consort Biosciences Man I

(1)

Corcept Therapeutics

(1)

CosMED Pharmaceutical

(1)

Cosmo Technologies

(1)

Covidien Pharmaceuticals

(1)

Crick Therapeutics Ltd

(1)

Crinetics Pharmaceuticals

(1)

Cspc Zhongqi Pharmaceutic

(1)

Cstone Pharmaceuticals Su

(1)

Curadev Pharma Pvt Ltd

(1)

Cytosite Biopharma

(1)

D & D Pharma Tech Inc

(1)

D E Shaw Research Llc

(1)

(1)

Daewoong Pharmaceutical C

(1)

Dalian Institute of Chemi

(1)

Daoyi Youdao Tianjin Phar

(1)

Daqing Xingmu Tech Co Ltd

(1)

Dennert William [us]; Den

(1)

Dhanoa Daljit Singh

(1)

(1)

(1)

Direct Biologics

(1)

(1)

Duality Biologics Shangha

(1)

Duality Biologics Suzhou

(1)

Duscentis Biotherapeutics

(1)

ENSEM Therapeutics

(1)

East China Normal Univers

(1)

East China Normal Univers

(1)

East China University of

(1)

Eidos Therapeutics

(1)

Eil Therapeutics

(1)

Eisai R&D Management

(1)

Electric Power Science Re

(1)

Eliaz Therapeutics Inc

(1)

(1)

En Otsuka Pharmaceutical

(1)

Enanta Pharmaceuticals

(1)

Encoded Therapeutics

(1)

Endocell Therapeutics Inc

(1)

Enkang Pharmaceutical Tec

(1)

Enterobiome Inc

(1)

(1)

Erchu of China Railway Tu

(1)

Esapharma S P A

(1)

Esperion Therapeutics

(1)

Eun Woo Pharm Co Ltd

(1)

Eustralis Pharmaceuticals

(1)

Exam Therapeutics Inc

(1)

Exoone Bio Co Ltd

(1)

Eye Hospital of China Aca

(1)

(1)

Fameccanica Data

(1)

Fang Zhang Hong

(1)

Farsight Medical Technolo

(1)

Feierfulai Biological Co

(1)

Feiman Changchun Pharmace

(1)

Fermenta Biotech Ltd

(1)

Fibrocor Therapeutics Inc

(1)

First People\'s Hospital

(1)

Flagship Pioneering Innov

(1)

Foreseen Technology Beiji

(1)

Formosa Laboratories Inc

(1)

Fortvita Biologics Inc

(1)

Forward Therapeutics Inc

(1)

Foshan Qihuang Chengkang

(1)

Fresenius Kabi USA

(1)

Frontier Pharmaceuticals

(1)

Fujian Rst Tech Co Ltd

(1)

Futuregen Biopharmaceutic

(1)

Fuzhou Neptunus Fuyao Pha

(1)

Fuzhou Tianweida Informat

(1)

(1)

GE Precision Medicine

(1)

GH Research, Ireland

(1)

Gan & Lee Pharmaceuticals

(1)

Gansu Keju Pharmaceutical

(1)

Gansu Normal Univ For Nat

(1)

Ganzhou Third People\'s H

(1)

(1)

Genchem & Genpharm Changz

(1)

(1)

Genentech Inc [us]; BioNT

(1)

Genentech Inc [us]; Ferma

(1)

Genentech Inc [us]; Hoffm

(1)

Genentech Inc [us]; Hoffm

(1)

Genentech Inc [us]; Regor

(1)

Genentech Inc [us]; Shang

(1)

Genentech Inc [us]; Xenco

(1)

Genentech; Pfizer

(1)

(1)

Genfleet Therapeutics Sha

(1)

Genmab As [dk]; BioNTech

(1)

Genmab As [dk]; T O A D O

(1)

Gento Pharmaceutical Co L

(1)

Georgia Tech Research Cor

(1)

Gewu Bio Co Ltd

(1)

GlaxoSmithKline Intellect

(1)

Glaxosmithkline Intellect

(1)

Global Blood Therapeutics

(1)

Glory Age Co Ltd

(1)

Governing Council Univ To

(1)

(1)

Guangdong Anjian Pharmace

(1)

Guangdong HEC Pharmaceuti

(1)

Guangdong Hongshanhu Phar

(1)

Guangdong Kingfa Scientif

(1)

Guangdong Lanyu Biotechno

(1)

Guangdong Wanguan Pharmac

(1)

Guangdong Xianfanggu Tech

(1)

Guangdong Yangble Biophar

(1)

Guangxi Chuanji Yiyangjin

(1)

Guangxi Normal University

(1)

Guangxi University of Chi

(1)

Guangxi Zhongzhitong Info

(1)

Guangzhou Baiyunshanzhong

(1)

Guangzhou Chuangrui Healt

(1)

Guangzhou Communications

(1)

Guangzhou Daguang Pharmac

(1)

Guangzhou Hanfang Pharmac

(1)

Guangzhou Hanmay Cosmetic

(1)

Guangzhou Jinan Univ Biop

(1)

Guangzhou Joyo Pharmatech

(1)

Guangzhou National Labora

(1)

Guangzhou Runlin Pharmace

(1)

Guangzhou Yajia Innovatio

(1)

Guangzhou Yuezhilian Inte

(1)

Guangzhou Zhenyantang Pha

(1)

Guilin Peoples Hospital

(1)

Guilin University of Elec

(1)

Guizhou Jinqianguo Biotec

(1)

Guizhou Natural Product R

(1)

Guizhou University of Tra

(1)

Guizhou Weikang Zifan Pha

(1)

Guizhou Xijiu; Tianjin Un

(1)

Gulang County Heisongyi T

(1)

Guozhong Kangjian Beijing

(1)

Haichang Biotech Co Ltd

(1)

Hainan Meien Kangxin Medi

(1)

Hainan Simcere Zaiming Ph

(1)

Hainan University

(1)

Haisco Pharmaceutical Gro

(1)

Halia Therapeutics Inc

(1)

(1)

Hanghzou Bio Sincerity Ph

(1)

Hangzhou China Resources

(1)

Hangzhou Chunhetang Healt

(1)

Hangzhou City Xiaoshan Di

(1)

Hangzhou First People\'s

(1)

Hangzhou Fst Pharmaceutic

(1)

Hangzhou Fukadi Biologica

(1)

Hangzhou Ganzhicao Tech C

(1)

Hangzhou Guorui Biotechno

(1)

Hangzhou Jianhai Tech Co

(1)

Hangzhou Jiechuangrui Med

(1)

Hangzhou Just Biotherapeu

(1)

Hangzhou Lionser Medical

(1)

Hangzhou Maidong Shukang

(1)

Hangzhou Polymed Biopharm

(1)

Hangzhou Shengyu Biomedic

(1)

Hangzhou Xianweida Biotec

(1)

Hangzhou Youjia Biomedica

(1)

Hanshou Hegang New Energy

(1)

Hansoh Bio Llc [us]; Shan

(1)

Hansoh Shanghai Health Te

(1)

Harbin Pharmaceutical Gro

(1)

(1)

Health Biomed Co Ltd

(1)

Health On Aging Bvba; Uni

(1)

Heartseed Inc; Keio Oki

(1)

Hebei Anguo Zhenyu Pharma

(1)

Hebei Anjian Chengyi Phar

(1)

Hebei University of Techn

(1)

Hefei Institutes of Physi

(1)

Hefei Tiangang Immunology

(1)

Heidelberg Pharma Researc

(1)

Heilongjiang Bayi Agricul

(1)

Heilongjiang Dilong Pharm

(1)

Helix Nanotechnologies

(1)

(1)

Henan Cancer Hospital; Th

(1)

Henan Genuine Biotechnolo

(1)

Henan Kujiukang Medicine

(1)

Henan Mingrui Pharmaceuti

(1)

Henan Psychiatric Hospita

(1)

Henan University

(1)

Henan University Huaihe H

(1)

Henghau Enterprise Co Ltd

(1)

Hepaitech Beijing Biophar

(1)

Hepion Pharmaceuticals In

(1)

Hexin Saier Suzhou Cell B

(1)

Heze Haoyuan Pharmaceutic

(1)

High Point Univ

(1)

Hoffmann La Roche [ch]; C

(1)

Hoffmann La Roche [ch]; R

(1)

Hoffmann La Roche; IBM

(1)

Hoffmann-La Roche

(1)

(1)

(1)

Hsj Achievement Conversio

(1)

Huaneng Lancang River Hyd

(1)

Huang Chen Hsuan

(1)

(1)

Huanggang Normal Universi

(1)

Huanghuai University

(1)

Huapu Shijiazhuang Pharma

(1)

Huashan Hospital, Fudan U

(1)

Huayi Taikang Pharmaceuti

(1)

Huayu Biotechnology (Tian

(1)

Huazhong University of Sc

(1)

Hubei Guangren Medicament

(1)

Hubei Jiangxia Laboratory

(1)

Hubei Lingsheng Pharmaceu

(1)

Hubei Merryclin Pharmaceu

(1)

Hubei Waterstone Bio Phar

(1)

Hubei Xili Pharmaceutical

(1)

Hubei Yinuorui Biological

(1)

Hubei Zhongyao Pharmaceut

(1)

Huiying Hubei Environment

(1)

Hunan Aikesong Health Man

(1)

Hunan Dongjian Pharmaceut

(1)

Hunan Maiji Biotechnology

(1)

Hunan Normal University;

(1)

Huzhou City Linghu Xinwan

(1)

Huzhou Zhanwang Pharmaceu

(1)

IP2IPO Innovations

(1)

Idorsia Pharmaceuticals

(1)

Ignis Therapeutics Suzhou

(1)

Ilesio Therapeutics Inc

(1)

Ilko Ilac Sanayi Ve Ticar

(1)

Immuneoncia Therapeutics

(1)

(1)

Impact Therapeutics Inc

(1)

Impact Therapeutics Shang

(1)

Impleson Pharmaceuticals

(1)

Incarved Co Ltd

(1)

Incyte Corp [us]; Syndax

(1)

Industry-university Coope

(1)

Inner Mongolia Medical Un

(1)

Inner Mongolia Normal Uni

(1)

Inner Mongolia People\'s

(1)

Inner Mongolia Research I

(1)

Inner Mongolia University

(1)

Innovec Biotherapeutics

(1)

Innovik Biotech Hong Kong

(1)

Innovstone Therapeutics

(1)

Inspection Therapeutics I

(1)

Inst For Basic Science [k

(1)

Inst Materia Medica Cams

(1)

Inst Med Biotechnology Ca

(1)

Institute of Chinese Mate

(1)

Institute of Materia Medi

(1)

Institute of Microbiology

(1)

Institute of Microbiology

(1)

Intellia Therapeutics

(1)

Intellus Biotherapeutics

(1)

(1)

(1)

Ireland 790 Co Ltd

(1)

Isomorphic Labs Ltd

(1)

Istituto Naz Per Lo Studi

(1)

Itf Res & Pharma Inc

(1)

Itf Res Pharma Slu

(1)

Jacoray Pharmaceutical Te

(1)

Janssen Pharmaceuticals

(1)

Japan As Represented By D

(1)

Javier Rene Dumalaog

(1)

Jazz Pharmaceuticals Irel

(1)

Jeil Pharmaceutical Co Lt

(1)

Ji Yan Biomedical Co Ltd

(1)

Jiajin Biological Medicin

(1)

Jianchangbang Chinese Her

(1)

Jianghan University

(1)

Jiangnan University; Jian

(1)

Jiangsu Carephar Pharmace

(1)

Jiangsu Chia Tai Fenghai

(1)

Jiangsu Chuangte Pharmace

(1)

Jiangsu College of Nursin

(1)

Jiangsu Flag Chemical Ind

(1)

Jiangsu Food & Pharmaceut

(1)

Jiangsu Handian Biotechno

(1)

Jiangsu Hengrui Medicine;

(1)

Jiangsu Hengrui Medicine;

(1)

Jiangsu Hengrui Pharmaceu

(1)

Jiangsu Jiahao Hot Melt A

(1)

Jiangsu Jiming Pharmaceut

(1)

Jiangsu Jinglixin Pharmac

(1)

Jiangsu Leeway Biological

(1)

Jiangsu Nhwa Pharmaceutic

(1)

Jiangsu Nuoge Biotechnolo

(1)

Jiangsu Pacific Meinuoke

(1)

Jiangsu Puxin Pharmaceuti

(1)

Jiangsu Rongzhitang Biolo

(1)

Jiangsu Szyy Pharmaceutic

(1)

Jiangsu Webest Medical Pr

(1)

Jiangsu Wuzhong Pharmaceu

(1)

Jiangsu Xidian Pharmaceut

(1)

Jiangsu Yabang Aipusen Ph

(1)

Jiangsu Yahong Meditech C

(1)

Jiangxi Disainuo Pharmace

(1)

Jiangxi Guangenhe Pharmac

(1)

Jiangxi Kerui Pharmaceuti

(1)

Jiangxi Lishikaoxian Zhul

(1)

Jiangxi Qingchun Kangyuan

(1)

Jiangxi Sincer Medical Co

(1)

Jiangyin Huacai Shijia Ne

(1)

Jiefu Molecular Tech Co L

(1)

Jilin University

(1)

Jilin Xiansu Pharmaceutic

(1)

Jilin Xiuzheng Pharmaceut

(1)

Jiming Pharmatech Suzhou

(1)

Jinan Micro Ecological Bi

(1)

Jinan Sanyuan Pharmaceuti

(1)

Jinan Tianju Animal Husba

(1)

Jinan University; Guangdo

(1)

Jing Brand; Jinpai Chizhe

(1)

Jingzhou Central Hospital

(1)

Jinhua Herui Life Health

(1)

Jinhua Longevity Valley B

(1)

Jinyao Heping Tianjin Pha

(1)

Jinzhong Comprehensive In

(1)

Jiujiang Hi Tech Pharmace

(1)

Johns Hopkins University

(1)

Jsk Biotech Inc

(1)

(1)

Junkang Medical Tech Tian

(1)

Junke Zhengyuan Tianjin B

(1)

K36 Therapeutics

(1)

Kadmon Corporation Llc

(1)

Kangbaida (Sichuan) Biote

(1)

(1)

Kestrel Therapeutics Inc

(1)

Keymed Biosciences Chengd

(1)

Kongdi Internet Tech Co L

(1)

Koni Life Tech Co Ltd; Hu

(1)

Korea Inst Of Science And

(1)

Korea University Research

(1)

Kumquat Biosciences

(1)

Kunming Institute of Bota

(1)

Kunming Institute of Zool

(1)

Kunming Lifeng Practical

(1)

Kunshan Jingwei New Mater

(1)

Kunshan Yingkai Precision

(1)

Kunyu Health Pharmaceutic

(1)

(1)

(1)

LTS Lohmann Therapie-Syst

(1)

LaNova Medicines

(1)

Laboratorios Farmaceutico

(1)

Laboratory for Synthetic

(1)

Laekna Pharmaceutical Nin

(1)

Laekna Therapeutics, Shan

(1)

Laikai Pharmaceutical Nin

(1)

Laikai Pharmaceutical Tec

(1)

Lankenau Inst For Medical

(1)

Lantern Pharma Inc

(1)

Lanzhou Institute Husband

(1)

Lask Pharma Inc

(1)

Launxp Biomedical Co Ltd

(1)

Lb Pharmaceuticals Inc

(1)

Lenz Therapeutics Operati

(1)

Levena Suzhou Biopharma C

(1)

Lexiao Liaoning Nano Biot

(1)

(1)

Li Jianwu; Lee In Seong;

(1)

(1)

Liaoning Cancer Hospital

(1)

Liaoning Misentang Pharma

(1)

Liaoning Oxiranchem Pharm

(1)

Libang Medicine Hong Kong

(1)

Lifeedit Therapeutics

(1)

Lilly Co Eli [us]; Proqr

(1)

(1)

Linyi Kangli Medical Equi

(1)

Lion Corporation

(1)

Liupanshui Animal Health

(1)

Livzon New North River Ph

(1)

Lixiang Weilai Dezhou Pla

(1)

Lonza Greenwood Llc

(1)

Lospoint Therapeutics Inc

(1)

Ltt Bio Pharma Co Ltd [jp

(1)

(1)

(1)

Lyu Genquine Biomedical U

(1)

M Path Biopharma Ltd

(1)

(1)

Mackay Memorial Hospital

(1)

(1)

Maha Therapeutics Inc

(1)

(1)

Marengo Therapeutics

(1)

Mariana Oncology

(1)

(1)

Marsal Therapeutics Inc

(1)

(1)

Matery Biotech Co Ltd

(1)

Medicalsystem Biotechnolo

(1)

Medigen Biotechnology Cor

(1)

Medilink Therapeutics Suz

(1)

Medilink Therapeutics, Su

(1)

(1)

(1)

Medimmune Llc [us]; Amgen

(1)

Medshine Discovery

(1)

Meiji Holdings Co Ltd

(1)

Mello Biotech Taiwan Co L

(1)

(1)

Merdury Biopharmaceutical

(1)

(1)

Meta Therapeutics Inc

(1)

Micin Inc [jp]; Takeda Ph

(1)

Microcirculation Inst Chi

(1)

(1)

Minghui Pharmaceutical Sh

(1)

Mirati Therapeutics

(1)

Mitchell International

(1)

Mitoimmune Therapeutics

(1)

Mitsubishi Tanabe Pharma

(1)

(1)

Monolithic Cell Therapeut

(1)

Monte Rosa Therapeutics

(1)

Mosanna Therapeutics Ag

(1)

Multiverse Pharma Inc

(1)

(1)

Nanfang Hospital, Souther

(1)

Nanjing Anmei Pharmaceuti

(1)

Nanjing City Gulou Distr

(1)

Nanjing Congjing Biotechn

(1)

Nanjing Drum Tower Hospit

(1)

Nanjing Feilikang Pharmac

(1)

Nanjing Fisheries Researc

(1)

Nanjing Hailing Pharmaceu

(1)

Nanjing Hanxin Pharmaceut

(1)

Nanjing Heron Pharmaceuti

(1)

Nanjing Huihong Pharmaceu

(1)

Nanjing Indetek Laborator

(1)

Nanjing Jiangning Hospita

(1)

Nanjing Lingxin Biotechno

(1)

Nanjing Medical Universit

(1)

Nanjing Polytechnic Insti

(1)

Nanjing Qingpu Biotechnol

(1)

Nanjing Tongnuokang Medic

(1)

Nanjing Vcare Bio Pharmac

(1)

Nanjing Well Pharmaceutic

(1)

Nanjing Xinbai Pharmaceut

(1)

Nanjing Xingyin Pharmaceu

(1)

Nanjing Zhihe Pharmaceuti

(1)

Nanjing Zhongkebaier Phar

(1)

Nanjing Zhongkebaier Phar

(1)

Nankai University

(1)

Nantong Huashan Pharmaceu

(1)

Nantong Huaxiang Pharmace

(1)

Nantong University

(1)

Nat Defense Medical Cente

(1)

National Cheng Kung Unive

(1)

National Defense Medical

(1)

National Health Res Inst

(1)

National Health Research

(1)

National Inst For Communi

(1)

National Research Institu

(1)

National Taiwan Universit

(1)

National Taiwan Universit

(1)

Navigo Proteins

(1)

Nerviano Medical Sciences

(1)

Neuboron Medtech Res Inst

(1)

Neurocrine Biosciences

(1)

Neuromusculoskeletal Rege

(1)

(1)

Nimbus Salacia Inc

(1)

Ningbo Cixi Inst Of Biome

(1)

Ningbo Ocean Pharmaceutic

(1)

Ningbo Yuanxin Electronic

(1)

Ningde Contemporary Amper

(1)

Ningxia Tianxin Pharmaceu

(1)

Ningxia University

(1)

Nippon Chemiphar Co

(1)

Nippon Shinyaku

(1)

Nissan Chemical

(1)

Nitrase Therapeutics Inc

(1)

Nkilt Therapeutics Inc

(1)

(1)

(1)

Noobs Therapeutics Inc

(1)

North China University of

(1)

Northridge Health Group H

(1)

Northwestern University

(1)

Novartis Pharma

(1)

Novelwise Pharmaceutical

(1)

(1)

Nuoyataier Medical Tech S

(1)

Nurix Therapeutics Inc [u

(1)

Nvida Therapeutics Inc

(1)

Nykode Therapeutics

(1)

(1)

(1)

Ocean Alchemists Llc

(1)

Odesai Therapeutics Inc

(1)

Odyssey Therapeutics

(1)

Oncopia Therapeutics Inc

(1)

Oncopia Therapeutics Inc

(1)

(1)

Ono Pharmaceutical

(1)

Opko Biologics Ltd

(1)

Optima Pharmaceuticals Ll

(1)

(1)

Orphai Therapeutics Inc

(1)

Osprey Biopharmaceuticals

(1)

Osta Therapeutics [fr]; C

(1)

Oyster Point Pharma

(1)

PLA Air Force Medical Uni

(1)

PTC Therapeutics

(1)

Panion & BF Biotech

(1)

Panzhihua Hospital of Chi

(1)

Parabilis Pharmaceuticals

(1)

Paragon Therapeutics

(1)

Paragon Therapeutics Inc

(1)

(1)

Park Strategic Venture Gr

(1)

Passage Bio Inc

(1)

Pegavision Corp [tw]; Fac

(1)

Persio Pharmaceuticals In

(1)

Pfizer [us]; CTXT Pty LTD

(1)

(1)

(1)

Pheast Therapeutics Inc

(1)

Phytotechai Co Ltd

(1)

Ping An Shionogi Co Ltd

(1)

Pliant Therapeutics

(1)

Point Biopharma Inc [us];

(1)

Postech Research and Busi

(1)

(1)

Precise Biopharma Pvt Ltd

(1)

President And Fellows Of

(1)

Procter & Gamble

(1)

Proya Cosmetics

(1)

(1)

(1)

Qide Pharmaceutical Tech

(1)

Qilu Animal Health Produc

(1)

Qilu Pharmaceutical

(1)

Qilu Pharmaceutical Co Lt

(1)

Qilu Pharmaceutical; Shan

(1)

Qilu University of Techno

(1)

Qin Jingran; Wenzhou Nanh

(1)

Qingdao Inst Marine Geolo

(1)

Qingdao Municipal Hospita

(1)

Qingdao Shuojing Biologic

(1)

Qingdao Traditional Chine

(1)

Qingdao Xingsai Biotechno

(1)

Quantx Biosciences Us Inc

(1)

Quanzhou Haichuang Pharma

(1)

Queen Mary University of

(1)

Quzhou People\'s Hospital

(1)

RaQualia Pharma

(1)

Ractigen Therapeutics

(1)

Radionetics Oncology Inc

(1)

Ramot At Tel Aviv Univ Lt

(1)

Country

X

China Patent News

Taiwan Patent News

European Patent News

WIPO Patent News

Status

X

1 - 100 of 1989 Items

Sign In / Subscribe

Select All

Share
Download as Excel
Download as PDF

Sanofi Seeks Patent for Last Dose Mechanism and Drug Delivery Device Herewith

Pharmaceutical

| Thu 18 Jun 2026

Geneva, June 19 -- Sanofi has sought patent for Last Dose Mechanism and Drug Delivery Device Herewith. This invention was developed by Veasey Robert Frederick, Plumptre David Aubrey, Draper Paul Richard and Wimpenny Steven. The patent application number is WO2025EP85219 20251203. The patent publication number is WO2026119952 ..

World Intellectual Property Organization Receives Monte Rosa Therapeutics Patent Application for Ccne1 Targeting Degraders

Pharmaceutical

| Thu 18 Jun 2026

Geneva, June 19 -- World Intellectual Property Organization has received Monte Rosa Therapeutics patent application for Ccne1 Targeting Degraders. Cabré Xavier Lucas, Ranieri Beatrice, Rasmusson Timothy, Harvey Freya, Mcallister Laura Ann and Fasching Bernhard developed the invention. The patent application number is WO2025EP8..

World Intellectual Property Organization Releases SHL Medical Patent Application for a Subassembly for a Medicament Delivery Device

Pharmaceutical

| Thu 18 Jun 2026

Geneva, June 19 -- World Intellectual Property Organization has released SHL Medical patent application for a Subassembly for a Medicament Delivery Device. This invention was developed by Alexandersson Oscar and Zander Johan. The patent application number is WO2025EP81734 20251104. The patent publication number is WO202611947..

World Intellectual Property Organization Releases China Pharmaceutical University Patent Application for N-(2',6'-dimethylphenyl)-2-piperidinecarboxamide Derivative and Use Thereof

Pharmaceutical

| Thu 18 Jun 2026

Geneva, June 19 -- World Intellectual Property Organization has released China Pharmaceutical University patent application for N-(2',6'-dimethylphenyl)-2-piperidinecarboxamide Derivative and Use Thereof. This invention was developed by Sha Yubin, Du Desheng, Chang Jiaxin, Chen Shuanglong, Guo Weiwei, Dong Xinyuan and Zheng Yueq..

Xellsmart Bio-Pharmaceutical (Suzhou) Seeks Patent for Use and Mechanism of Motor Nerve Progenitor Cell Population for Treating Spinal Cord Injury Diseases

Pharmaceutical

| Thu 18 Jun 2026

Geneva, June 19 -- Xellsmart Bio-Pharmaceutical (Suzhou) has sought patent for Use and Mechanism of Motor Nerve Progenitor Cell Population for Treating Spinal Cord Injury Diseases. This invention was developed by Zhu Jianghua, Cheng Lin and Li Xiang. The patent application number is WO2025CN140548 20251205. The patent publicati..

World Intellectual Property Organization Releases Hangzhou Zhongmei Huadong Pharmaceutical Patent Application for Formamide Compound Having WRN Inhibitory Effect and Use Thereof

Pharmaceutical

| Thu 18 Jun 2026

Geneva, June 19 -- World Intellectual Property Organization has released Hangzhou Zhongmei Huadong Pharmaceutical patent application for Formamide Compound Having WRN Inhibitory Effect and Use Thereof. This invention was developed by Zhang Zhimin, Zheng Yongyong, Qian Meijia, E Jingwen, Wang Zhiyong and Liu Dongzhou. The patent..

Zhejiang Teruisi Pharmaceutical Submits Patent Application for Drug for Treating Transformed Diffuse Large B-cell Lymphoma and Use Thereof

Pharmaceutical

| Thu 18 Jun 2026

Geneva, June 19 -- Zhejiang Teruisi Pharmaceutical has submitted a patent application for Drug for Treating Transformed Diffuse Large B-cell Lymphoma and Use Thereof. Huang Kai and Wang Chen developed the invention. The patent application number is WO2025CN140194 20251205. The patent publication number is WO2026119257 (A1). Int..

World Intellectual Property Organization Receives Guangdong Raynovent Biotechnology Patent Application for Pyrimidine Derivative-containing Pharmaceutical Composition and Use There..

Pharmaceutical

| Thu 18 Jun 2026

Geneva, June 19 -- World Intellectual Property Organization has received Guangdong Raynovent Biotechnology patent application for Pyrimidine Derivative-containing Pharmaceutical Composition and Use Thereof. Wan Chunxi, Liu Zhuowei, Ou Kunyong, Liu Zhiqiang, Long Chaofeng, Xu Xin and Chen Xiaoxin developed the invention. The pat..

Guangdong Raynovent Biotechnology Submits WIPO Patent Application for Oral Solid Pharmaceutical Composition, Preparation Method Therefor, and Use Thereof

Pharmaceutical

| Thu 18 Jun 2026

Geneva, June 19 -- Guangdong Raynovent Biotechnology has submitted a patent application for Oral Solid Pharmaceutical Composition, Preparation Method Therefor, and Use Thereof. This invention was developed by Wan Chunxi, Liu Zhuowei, Ou Kunyong, Liu Zhiqiang, Long Chaofeng, Xu Xin and Chen Xiaoxin. The patent application number..

Haisco Pharmaceutical Group Submits WIPO Patent Application for Tricyclic BTK Degradation Agent and Use Thereof in Medicine

Pharmaceutical

| Thu 18 Jun 2026

Geneva, June 19 -- Haisco Pharmaceutical Group has submitted a patent application for Tricyclic BTK Degradation Agent and Use Thereof in Medicine. This invention was developed by Zhang Chen, Liao Yuting, Yan Pangke and Li Yao. The patent application number is WO2025CN139901 20251204. The patent publication number is WO2026119..

World Intellectual Property Organization Releases Haisco Pharmaceutical Group Patent Application for LPAR1 Antagonist Pharmaceutical Composition and Pharmaceutical Use Thereof

Pharmaceutical

| Thu 18 Jun 2026

Geneva, June 19 -- World Intellectual Property Organization has released Haisco Pharmaceutical Group patent application for LPAR1 Antagonist Pharmaceutical Composition and Pharmaceutical Use Thereof. This invention was developed by Dou Ying, Zhang Chen, Chen Lei, Tang Pingming, Zhang Xuanmiao, Zhang Haoliang, Li Yao, Ren Lei, Zh..

Zhejiang Fresh Pharmaceutical Submits Patent Application for Method for Detecting Related Substances of Budesonide Suspension for Inhalation

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Zhejiang Fresh Pharmaceutical has submitted a patent application for Method for Detecting Related Substances of Budesonide Suspension for Inhalation. Xia Yanhua, Meng Chao, Shi Dangsheng, Fu Lihua and Xie Hongmei developed the invention. The patent application number is CN20251246283 20251231. The patent pub..

Wuxi Zishan Pharmaceutical Applies for Patent on Method for Detecting N-methyl Pyrrolidone in Carfilzomib Intermediate

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Wuxi Zishan Pharmaceutical has applied Chinese patent for Method for Detecting N-methyl Pyrrolidone in Carfilzomib Intermediate. Qian Yibo, Zhang Li, Xie Yuxing, Liu Guifang and Wang Xuyang developed it. The patent application number is CN202511966582 20251224. The patent publication number is CN121633347 (A..

Shaanxi University of Science & Technology Submits Chinese Patent Application for Compound Melanterite Pill Specific Chromatogram and Construction Method and Quality Detection Meth..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Shaanxi University of Science & Technology has submitted a patent application for Compound Melanterite Pill Specific Chromatogram and Construction Method and Quality Detection Method Thereof. This invention was developed by Wei Meiyan, Wang Yujing, Wang Mengzhou, Liang Chengyuan, Li Han, Wang Yongbo, Yuan Yua..

Ruijin Hospital Shanghai Jiao Tong University School of Medicine Seeks Patent for Serum Marker Combination and Analysis System for Predicting Significant Fibrosis of Masld

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Ruijin Hospital Shanghai Jiao Tong University School of Medicine has sought patent for Serum Marker Combination and Analysis System for Predicting Significant Fibrosis of Masld. This invention was developed by Xie Cen, Cao Zhujun, Li Jiaqi, Xie Qing, Song Shuying, Du Bingying, Huang Yan and Guo Xiaozhen. The..

Chengdu Qingshan Likang Pharmaceutical Submits Patent Application for Method for Detecting Lactic Acid in Displacement Liquid

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Chengdu Qingshan Likang Pharmaceutical has submitted a patent application for Method for Detecting Lactic Acid in Displacement Liquid. Li Miaomiao, Tian Weiqin and Cheng Long developed the invention. The patent application number is CN202411237432 20240904. The patent publication number is CN121633314 (A). I..

State Intellectual Property Office of China Releases Kamp Pharmaceutical Patent Application for Method for Detecting Related Substances in Eldoxaban Tosylate Medicine

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has released Kamp Pharmaceutical patent application for Method for Detecting Related Substances in Eldoxaban Tosylate Medicine. This invention was developed by Zeng Shiyi, Liu Juan, Xiang Yuehui, Zuo Yiming, Yang Shiping, He Lian and Zhang Jing. The patent applicat..

Kamp Pharmaceutical Applies for Patent on Detection Method of Coenzyme Q10 Injection

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Kamp Pharmaceutical has applied Chinese patent for Detection Method of Coenzyme Q10 Injection. Zeng Shiyi, Liu Juan, Yang Shiping, He Lian, Hu Li and Zhang Jing developed it. The patent application number is CN202411202375 20240829. The patent publication number is CN121633301 (A). International Patent Class..

State Intellectual Property Office of China Publishes Fudan University Patent Application for Method for Identifying Chaenomeles Speciosa and Chaenomeles Speciosa as Traditional Ch..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has published Fudan University patent application for Method for Identifying Chaenomeles Speciosa and Chaenomeles Speciosa as Traditional Chinese Medicinal Materials. The invention was developed by Huang Jisheng and Cheng Zhihong. The patent application number is C..

State Intellectual Property Office of China Receives Tianjin University Patent Application for Ultrasonic Nondestructive Testing System and Method for Interface Defects of Epoxy Re..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has received Tianjin University patent application for Ultrasonic Nondestructive Testing System and Method for Interface Defects of Epoxy Resin Component. Zhang Bo, Wang Yaxiang, Yuan Duanpeng, Li Jin, Chen Yun, Du Boxue, Ren Shuai, Wang Ning, Li Guodong, He Jin, Xi..

Tianjin University of Science & Technology Submits Patent Application for Pine Tree Type Pipeline Corrosion Detection Device

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Tianjin University of Science & Technology has submitted a patent application for Pine Tree Type Pipeline Corrosion Detection Device. Wang Hao, Pan Yiquan, Ding Lei, Lu Xiangdong, Gao Xi and Fan Dongwang developed the invention. The patent application number is CN202610162231 20260205. The patent publication..

Guangdong Pharmaceutical University Submits Chinese Patent Application for Efficient Paraffin Section Technical Method for Observing Different Developmental Stages of Cinnamon Vasc..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Guangdong Pharmaceutical University has submitted a patent application for Efficient Paraffin Section Technical Method for Observing Different Developmental Stages of Cinnamon Vascular Tissue. This invention was developed by Tan Langwen, Xu Gang and Yang Quan. The patent application number is CN202511839201 ..

Novartis Files WIPO Patent Application for NLRP3 Inhibitor for Use in Treating Myeloid Diseases

Pharmaceutical

| Fri 19 Jun 2026

Geneva, June 19 -- Novartis has filed a patent application for NLRP3 Inhibitor for Use in Treating Myeloid Diseases. This invention was developed by Gonzalez-maffe Juan, Carreon Daniel, Beaulieu Valerie, Singh Arti, Li Yutong, Woo Janghee, Gatlik Ewa and Rauch Philipp. The patent application number is WO2025IB62426 20251204. Th..

Novartis Submits Patent Application for Stable Radionuclide Complex Solutions

Pharmaceutical

| Fri 19 Jun 2026

Geneva, June 19 -- Novartis has submitted a patent application for Stable Radionuclide Complex Solutions. Dell'isola Antonio, Bicocchi Giacomo, Tedesco Mattia and Ferrero Valentina Elisabetta Viviana developed the invention. The patent application number is WO2025IB62362 20251203. The patent publication number is WO2026120497 (..

State Intellectual Property Office of China Releases Shanghai Jiao Tong University Patent Application for Nanoscale Temperature Measurement Method Based on Four-dimensional Scannin..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has released Shanghai Jiao Tong University patent application for Nanoscale Temperature Measurement Method Based on Four-dimensional Scanning Electron Diffraction. This invention was developed by Wu Tianru, Wei Weiran, Wang Yan, Zhou Wenbo, Du Qian, Zhang Tianyu, Sh..

Tianjin University Submits Chinese Patent Application for Multi-storey Residential Building Toilet Linkage Ventilation System and Intelligent Control Method

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 19 -- Tianjin University has submitted a patent application for Multi-storey Residential Building Toilet Linkage Ventilation System and Intelligent Control Method. This invention was developed by Chen Ziyi, Xu Dayan, Cho Jung and Liu Dehan. The patent application number is CN20261082208 20260121. The patent public..

Ascendis Pharma Submits WIPO Patent Application for Novel Long-acting Degrader Conjugates

Pharmaceutical

| Thu 18 Jun 2026

Geneva, June 19 -- Ascendis Pharma has submitted a patent application for Novel Long-acting Degrader Conjugates. This invention was developed by Sprogøe Kennett, Weisbrod Samuel, Laufer Burkhardt, Grabe Tobias, Nyegaard Steffen, Knappe Thomas, Bisek Nicola and Barthelme Dominik. The patent application number is WO2025EP85738 2..

Ascendis Pharma Seeks Patent for Conjugates Comprising an Aromatic Carbamate-derived Reversible Linker

Pharmaceutical

| Thu 18 Jun 2026

Geneva, June 19 -- Ascendis Pharma has sought patent for Conjugates Comprising an Aromatic Carbamate-derived Reversible Linker. This invention was developed by Weisbrod Samuel. The patent application number is WO2025EP85737 20251205. The patent publication number is WO2026120176 (A1). International Patent Classification codes a..

State Intellectual Property Office of China Releases Shanghai Jiao Tong University Patent Application for Semi-active Quasi-zero Stiffness Torsional Vibration Isolation Device

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has released Shanghai Jiao Tong University patent application for Semi-active Quasi-zero Stiffness Torsional Vibration Isolation Device. This invention was developed by Zhang Xu, Ge Fuyu, Wang Tongfei, Xu Jiawei, Zhang Jiajing, Jing Jianping, Duan Xianbo and Lin Xua..

Chiesi Farmaceutici Seeks Patent for Azaspiroheptane Derivatives as Ddr Inhibitors

Pharmaceutical

| Thu 18 Jun 2026

Geneva, June 19 -- Chiesi Farmaceutici has sought patent for Azaspiroheptane Derivatives as Ddr Inhibitors. This invention was developed by Giuliani Marta and Carzaniga Laura. The patent application number is WO2025EP85371 20251203. The patent publication number is WO2026120024 (A1). International Patent Classification codes ar..

Chiesi Farmaceutici Submits WIPO Patent Application for Azaspiroheptane Derivatives as Ddr Inhibitors

Pharmaceutical

| Thu 18 Jun 2026

Geneva, June 19 -- Chiesi Farmaceutici has submitted a patent application for Azaspiroheptane Derivatives as Ddr Inhibitors. This invention was developed by Giuliani Marta, Carzaniga Laura and Whittaker Benjamin Paul. The patent application number is WO2025EP85368 20251203. The patent publication number is WO2026120023 (A1). In..

Hoffmann La Roche Submits Chinese Patent Application for Reducing Interference in Immunoassays

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Hoffmann La Roche has submitted a patent application for Reducing Interference in Immunoassays. This invention was developed by Zant Toralf, Upmeier Barbara, Mock Thomas and Polz Johannes. The patent application number is CN202511838551 20190313. The patent publication number is CN121633476 (A). Internationa..

State Intellectual Property Office of China Publishes Hoffmann La Roche Patent Application for Reducing Interference in Immunoassays

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has published Hoffmann La Roche patent application for Reducing Interference in Immunoassays. The invention was developed by Zant Toralf, Upmeier Barbara, Mock Thomas and Polz Johannes. The patent application number is CN202511838549 20190313. The patent publicatio..

Santen Pharmaceutical Files WIPO Patent Application for Photostabilized Formulation of Aqueous Atropine-containing Pharmaceutical Composition and Photostabilization Method Therefor

Pharmaceutical

| Fri 19 Jun 2026

Geneva, June 19 -- Santen Pharmaceutical has filed a patent application for Photostabilized Formulation of Aqueous Atropine-containing Pharmaceutical Composition and Photostabilization Method Therefor. This invention was developed by Nakayama Sachie and Endo Yoko. The patent application number is WO2025JP42502 20251205. The pat..

State Intellectual Property Office of China Receives Shanghai Kaibao Pharmaceutical Patent Application for Method for Detecting Positive Ions in Phlegm-heat Clearing Injection

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has received Shanghai Kaibao Pharmaceutical patent application for Method for Detecting Positive Ions in Phlegm-heat Clearing Injection. Hu Qing, Cheng Yiqing, Shen Shasha, Xue Dongsheng, Yuan Yuan and Ma Mengjie developed the invention. The patent application numb..

State Intellectual Property Office of China Publishes Shandong Xinhua Pharmaceutical Patent Application for Method for Determining Impurity Content in Oab-14 by High Performance Li..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has published Shandong Xinhua Pharmaceutical patent application for Method for Determining Impurity Content in Oab-14 by High Performance Liquid Chromatography. The invention was developed by Cao Lili, Zheng Zhonghui, Chen Guoliang, Liu Na, Wang Furong, Wu Hui, Wang..

West China 2nd University, Hospital of Sichuan University Files Chinese Patent Application for Use of Medicament for Inhibiting Progression of Glioma Promoted by Chronic Pressure S..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- West China 2nd University, Hospital of Sichuan University has filed a patent application for Use of Medicament for Inhibiting Progression of Glioma Promoted by Chronic Pressure Stress. This invention was developed by Zheng Bohao, Zhou Shengtao, Yang Zhengnan and Zhao Linju. The patent application number is C..

Hainan University Seeks Patent for Application of Sesquiterpene Variecolactone in Preparation of Medicine for Treating Alzheimer's Disease

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Hainan University has sought patent for Application of Sesquiterpene Variecolactone in Preparation of Medicine for Treating Alzheimer's Disease. This invention was developed by Fu Tingting, Fu Ying, Xiong Wandi, Huang Ling, Shi Yujia and Yang Zhonglin. The patent application number is CN20251203246 20251229...

Changzhou University Submits Chinese Patent Application for Application of Trn in Preparation of Medicine for Preventing or Treating Depression and Anxiety

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Changzhou University has submitted a patent application for Application of Trn in Preparation of Medicine for Preventing or Treating Depression and Anxiety. This invention was developed by Pan Hong, Ren Jie and Hu Kun. The patent application number is CN202511797965 20251202. The patent publication number is..

Chengdu Institute Biology CAS Submits Patent Application for Application of Penicillamine in Preparation of Medicine for Preventing and Treating Noise-induced Deafness

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Chengdu Institute Biology CAS has submitted a patent application for Application of Penicillamine in Preparation of Medicine for Preventing and Treating Noise-induced Deafness. Li Runhan, Cui Jianguo, Wang Lu, Zhu Bicheng and Cheng Cheng developed the invention. The patent application number is CN20251184746..

Binzhou Medical College Submits Chinese Patent Application for Application of Dicafen Phenolic Acid and Derivatives Thereof in Preparation of Medicine for Treating Pulmonary Fibros..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Binzhou Medical College has submitted a patent application for Application of Dicafen Phenolic Acid and Derivatives Thereof in Preparation of Medicine for Treating Pulmonary Fibrosis. This invention was developed by Cao Qizhi, Qu Guiwu and Song Shuling. The patent application number is CN20251234927 20251230..

State Intellectual Property Office of China Publishes The Second Affiliated Hospital of Nanjing Medical University Patent Application for Application of Alpha-ketoglutaric Acid in ..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has published The Second Affiliated Hospital of Nanjing Medical University patent application for Application of Alpha-ketoglutaric Acid in Preparation of Medicine for Preventing and/or Treating Antibody-mediated Rejection Reaction. The invention was developed by Gu..

Changzhou University Submits Chinese Patent Application for Application of Sofalcone as Trpv3 Inhibitor in Preparation of Medicine for Treating Skin Diseases

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Changzhou University has submitted a patent application for Application of Sofalcone as Trpv3 Inhibitor in Preparation of Medicine for Treating Skin Diseases. This invention was developed by Wang Yajing, Lyu Jing and Huang Xianfeng. The patent application number is CN202511896509 20251216. The patent publica..

The Third Xiangya Hospital of Central South University Applies for Patent on Application of D-(+)-phenyllactic Acid in Preparation of Medicine for Preventing or Treating Sepsis

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- The Third Xiangya Hospital of Central South University has applied Chinese patent for Application of D-(+)-phenyllactic Acid in Preparation of Medicine for Preventing or Treating Sepsis. Cai Jizhen, Liang Xiaoqi, Yan Zhengzheng, Yuan Fangfang, Li Zhaozheng and Yang Lei developed it. The patent application nu..

State Intellectual Property Office of China Receives Jianghan University Patent Application for Application of Vitamin K2 in Biphasic Regulation of Er-alpha36 Expression and Hepato..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has received Jianghan University patent application for Application of Vitamin K2 in Biphasic Regulation of Er-alpha36 Expression and Hepatoma Carcinoma Cell Growth. Fu Zhengqi, Wu Zhuorui, Qiao Jiaqi and Wang An developed the invention. The patent application nu..

University Jining Medical Applies for Patent on Application of Pterostilbene in Preparation of Medicine for Preventing or Treating Dyszoospermia

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- University Jining Medical has applied Chinese patent for Application of Pterostilbene in Preparation of Medicine for Preventing or Treating Dyszoospermia. Liu Chao, Li Xiao, Fan Kunzheng, Liu Zhiqiang, Ren Yan, Gao Huijie, Wang Xin and Liang Wenjing developed it. The patent application number is CN2025112642..

State Intellectual Property Office of China Releases Inner Mongolia Medical University Patent Application for Intelligent Cantharidin Drug Delivery System

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has released Inner Mongolia Medical University patent application for Intelligent Cantharidin Drug Delivery System. This invention was developed by Xu Pengcheng. The patent application number is CN20261096767 20260123. The patent publication number is CN121550184 (..

Shanghai Jinbuhuan Lankao Pharmaceutical Submits Chinese Patent Application for Centrifugal Granulation Process for Producing Slow-release Indapamide

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Shanghai Jinbuhuan Lankao Pharmaceutical has submitted a patent application for Centrifugal Granulation Process for Producing Slow-release Indapamide. This invention was developed by Zhu Meijuan, Zhou Jing, Ding Long, Zhang Jiqian, Li Shang, Zhang Baolei, Yang Guodi, Hu Qiuge, Li Chunfeng, Bian Longxiang, Yao..

Shanghai Gongyi Pharmaceutical Submits Chinese Patent Application for Albendazole Suspension Preparation and Preparation Method Thereof

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Shanghai Gongyi Pharmaceutical has submitted a patent application for Albendazole Suspension Preparation and Preparation Method Thereof. This invention was developed by Liao Xueling and Xu Yuming. The patent application number is CN20261045116 20260114. The patent publication number is CN121550150 (A). Inter..

China Pharmaceutical University Submits Patent Application for Thermo-sensitive Double-layer Gel Containing Parp Inhibitor and Application of Thermo-sensitive Double-layer Gel

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- China Pharmaceutical University has submitted a patent application for Thermo-sensitive Double-layer Gel Containing Parp Inhibitor and Application of Thermo-sensitive Double-layer Gel. Tu Jiasheng, Sun Chunmeng, Wang Shengyi, Chen Qian, Cao Yiyang, Xu Zhenyu and Song Jianing developed the invention. The pate..

Tianjin University Submits Chinese Patent Application for High-sensitivity Blood Glucose Noninvasive Detection Method and System Based on Polarization Terahertz Photoacoustic

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Tianjin University has submitted a patent application for High-sensitivity Blood Glucose Noninvasive Detection Method and System Based on Polarization Terahertz Photoacoustic. This invention was developed by Li Jiao, Tian Zhen, Du Kepei and Wang Kun. The patent application number is CN20261035022 20260112. T..

Shanghai Jiao Tong University Applies for Patent on Blood Pressure Monitoring Method and Device

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Shanghai Jiao Tong University has applied Chinese patent for Blood Pressure Monitoring Method and Device. Yi Zhiran, Zhang Wenming and Xia Yuhang developed it. The patent application number is CN202511784942 20251128. The patent publication number is CN121549784 (A). International Patent Classification codes..

Women and Childrens Medical Center of Guangzhou Medical University Submits Patent Application for Application of Piezo1 Inhibitor in Preparation of Medicine for Preventing and Trea..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Women and Childrens Medical Center of Guangzhou Medical University has submitted a patent application for Application of Piezo1 Inhibitor in Preparation of Medicine for Preventing and Treating Esophageal Stenosis. Gong Sitang, Xiang Li, Niu Rongwei, Wang Hongli, Zhao Junhong, Cheng Yang, Xu Wanfu, Ye Liping, ..

Zhongshan Ophthalmic Center, Sun Yat-sen University Files Chinese Patent Application for Application of VEGF-b in Psoriasis

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Zhongshan Ophthalmic Center, Sun Yat-sen University has filed a patent application for Application of VEGF-b in Psoriasis. This invention was developed by Li Xuri and Lu Weisi. The patent application number is CN20261098833 20260126. The patent publication number is CN121550402 (A). International Patent Cl..

The Third Xiangya Hospital of Central South University Submits Patent Application for Application of Cryab in Preparation of Medicine for Preventing or Treating Psoriasis

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- The Third Xiangya Hospital of Central South University has submitted a patent application for Application of Cryab in Preparation of Medicine for Preventing or Treating Psoriasis. Chen Jing, Lei Li, Zeng Qinghai and Liang Yixuan developed the invention. The patent application number is CN20261069611 20260120..

Nantong University Submits Patent Application for Application of Beauveria Bassiana in Preparation of Medicine for Treating Pulmonary Fibrosis

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Nantong University has submitted a patent application for Application of Beauveria Bassiana in Preparation of Medicine for Treating Pulmonary Fibrosis. Xu Liqin, Zhang Erhao, Zhang Yufei, Cui Jianan, Yu Siyi, Wang Xiaoyao and Guan Jinghan developed the invention. The patent application number is CN2025118283..

Beijing Friendship Hospital, Capital Medical University Applies for Patent on Traditional Chinese Medicine Composition for Sensitizing Immune Checkpoint Inhibitor to Treat Microsat..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Beijing Friendship Hospital, Capital Medical University has applied Chinese patent for Traditional Chinese Medicine Composition for Sensitizing Immune Checkpoint Inhibitor to Treat Microsatellite Stable Tumors. Zhang Yu, Cao Bangwei, Qin Jiaan, Yan Dan, Liu Xiaojia, Zhao Wei, Wang Aiting and Long Jianglan dev..

Shenzhen Bao'an Traditional Chinese Medicine Hospital Submits Patent Application for Traditional Chinese Medicine Composition for Treating Senile Cognitive Impairment with Sarcopen..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Shenzhen Bao'an Traditional Chinese Medicine Hospital has submitted a patent application for Traditional Chinese Medicine Composition for Treating Senile Cognitive Impairment with Sarcopenia and Preparation Method Thereof. Li Han, Mei Quanxi and Liang Qi developed the invention. The patent application number..

Hangzhou Hospital of Traditional Chinese Medicine Hangzhou Hospital of Traditional Chinese Medicine Applies for Patent on Fat-reducing Medicinal and Edible Formula for Promoting Ra..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Hangzhou Hospital of Traditional Chinese Medicine Hangzhou Hospital of Traditional Chinese Medicine has applied Chinese patent for Fat-reducing Medicinal and Edible Formula for Promoting Rapid Metabolism and Excretion of Fat and Preparation Method of Fat-reducing Medicinal and Edible Formula. Wei Yan develope..

Wangjing Hospital of CACMS Institute of Orthopedics and Traumatology China Academy of Chinese Medical Science Submits Patent Application for Traditional Chinese Medicine Compositio..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Wangjing Hospital of CACMS Institute of Orthopedics and Traumatology China Academy of Chinese Medical Science has submitted a patent application for Traditional Chinese Medicine Composition for Treating Gastroesophageal Reflux Cough and Preparation Method Thereof. Feng Xuemei, Dong Yongli, Wang Bin, Gao Feng ..

China Institute for Radiation Protection Submits Chinese Patent Application for Natural Medicine Extract for Radiation Damage Protection

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- China Institute for Radiation Protection has submitted a patent application for Natural Medicine Extract for Radiation Damage Protection. This invention was developed by Liu Huan, Jin Hongtao, Li Jianhua, Li Jianguo and Li Wanfang. The patent application number is CN202511898817 20251216. The patent publicat..

State Intellectual Property Office of China Receives Guilin Peoples Hospital Patent Application for Traditional Chinese Medicine Composition for Treating Weakness and Night Sweat A..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has received Guilin Peoples Hospital patent application for Traditional Chinese Medicine Composition for Treating Weakness and Night Sweat After Illness and Preparation Method of Traditional Chinese Medicine Composition. Yu Zhiling, Liang Min and Tang Pingyan develo..

State Intellectual Property Office of China Receives Guangdong Pharmaceutical University Patent Application for Preparation Method of Traditional Chinese Medicine Composition and A..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has received Guangdong Pharmaceutical University patent application for Preparation Method of Traditional Chinese Medicine Composition and Application of Traditional Chinese Medicine Composition in Preparation of Medicine for Preventing and Treating Hypertrophic Car..

State Intellectual Property Office of China Releases Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Shanghai University of Traditional Patent Application f..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has released Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Shanghai University of Traditional patent application for Nasal Irrigation Traditional Chinese Medicine Composition for Treating Allergic Rhinitis, Traditional Chinese Medicine Prep..

University Jining Medical Applies for Patent on Traditional Chinese Medicine Composition for Improving Depression as Well as Preparation Method and Application of Traditional Chine..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- University Jining Medical has applied Chinese patent for Traditional Chinese Medicine Composition for Improving Depression as Well as Preparation Method and Application of Traditional Chinese Medicine Composition. Dang Zhaojin, Cai Tianyu, Zhu Mengrui, Gao Lina, Zhao Yijin, Fang Lifeng, Yang Qian, You Jinxue ..

State Intellectual Property Office of China Releases Kunming University of Science and Technology Patent Application for Poria Cocos Stump Wood Powder and Application of Extract of..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has released Kunming University of Science and Technology patent application for Poria Cocos Stump Wood Powder and Application of Extract of Poria Cocos Stump Wood Powder in Preparation of Medicine or Aromatherapy Product for Improving Sleep. This invention was deve..

First Affiliated Hospital Medical College Xi'an Jiaotong University Applies for Patent on Application of Turicibacter Sanguinis in Preparation of Medicine for Preventing and/or Tre..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- First Affiliated Hospital Medical College Xi'an Jiaotong University has applied Chinese patent for Application of Turicibacter Sanguinis in Preparation of Medicine for Preventing and/or Treating Depression. Gao Yuan, Ma Xiancang, Gao Fengjie, Cao Zhen and Gou Ningzhi developed it. The patent application nu..

Shenyang Pharmaceutical University Seeks Patent for Compound Composition Based on Radix Puerariae, Radix Scutellariae and Ligation Decoction

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Shenyang Pharmaceutical University has sought patent for Compound Composition Based on Radix Puerariae, Radix Scutellariae and Ligation Decoction. This invention was developed by Yan Hui, Zhang Hong, Sun Wanyang, Zhang Jianglei, Cai Ming, Hu Xuejiao, Zhang Zhenwei, Sun Guoxiang, Zhang Liuwei, Hu Yanlei and La..

State Intellectual Property Office of China Releases Shenzhen Second People's Hospital Shenzhen Institute of Translational Medicine Patent Application for Application of Troxerutin..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has released Shenzhen Second People's Hospital Shenzhen Institute of Translational Medicine patent application for Application of Troxerutin in Medicine for Preventing and Treating Ototoxicity Induced by Cis-platinum. This invention was developed by Liu Yang, Nie Gu..

South West University Submits Chinese Patent Application for Application of Vitamin B2 in Preparation of Product for Inhibiting or Killing Microsporidia

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- South West University has submitted a patent application for Application of Vitamin B2 in Preparation of Product for Inhibiting or Killing Microsporidia. This invention was developed by Jiang Haiyi, Liu Fangyan, Zhou Weilinlin, Zhou Zeyang, Chen Jie and Pan Guoqing. The patent application number is CN2025117..

State Intellectual Property Office of China Receives West China Hospital, Sichuan University Patent Application for Application of Xanthine Derivative in Preparation of Medicine fo..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has received West China Hospital, Sichuan University patent application for Application of Xanthine Derivative in Preparation of Medicine for Preventing And/or Treating Fatty Liver Disease Related to Metabolic Dysfunction. Tian Yan, Cao Rong and Fu Xianghui develope..

Suicheng Pharmaceutical Applies for Patent on Refining Method of Dextroborneol Crude Product

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Suicheng Pharmaceutical has applied Chinese patent for Refining Method of Dextroborneol Crude Product. Wu Xiaojun, Lu Qinwei, Yang Fei, Guo Haibo, Zhou Hongjian, Ma Hongli, Sun Xiaopeng, Lu Junru, Li Yang, Meng Xin, Shi Xiufang, Li Junxia, Zhou Wenwei, Zhou Ziyan, Zhao Xiang, Feng Yunxia and Liu Nana develope..

State Intellectual Property Office of China Publishes Shanghai Jiao Tong University Patent Application for Heat Treatment Method for Nickel-based Alloy Formed by Melting of Laser P..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has published Shanghai Jiao Tong University patent application for Heat Treatment Method for Nickel-based Alloy Formed by Melting of Laser Powder Bed and Application of Heat Treatment Method. The invention was developed by Kong Decheng, Chen Wen, Sun Baode, Zhu Guol..

First Affiliated Hospital Medical College Xi'an Jiaotong University Submits Chinese Patent Application for Tablet Grinding Device for Pharmaceutical Research

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- First Affiliated Hospital Medical College Xi'an Jiaotong University has submitted a patent application for Tablet Grinding Device for Pharmaceutical Research. This invention was developed by Zhuo Yingchen, Liu Yaqian and Ren Xiaodong. The patent application number is CN202511887788 20251215. The patent publi..

Tianjin University of Science & Technology Submits Chinese Patent Application for Preparation Method of Waste Bio-based Modified Material and Application of Waste Bio-based Modifie..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Tianjin University of Science & Technology has submitted a patent application for Preparation Method of Waste Bio-based Modified Material and Application of Waste Bio-based Modified Material in Removal of Microplastics in Water. This invention was developed by Niu Ben, Liang Yuhan, Liu Xinmiao, Ye Zilin, Chen..

Jiangsu Zhiyuan Pharmaceutical Files Chinese Patent Application for Equipment for Preparing Clobetasol Propionate Liniment and Preparation Method of Clobetasol Propionate Liniment

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Jiangsu Zhiyuan Pharmaceutical has filed a patent application for Equipment for Preparing Clobetasol Propionate Liniment and Preparation Method of Clobetasol Propionate Liniment. This invention was developed by Cai Beilei. The patent application number is CN202511635623 20251110. The patent publication numbe..

Shanghai Jiao Tong University Submits Chinese Patent Application for Double-tower Carbon Capture System Based on Negative Pressure Steam Purging Circulation

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Shanghai Jiao Tong University has submitted a patent application for Double-tower Carbon Capture System Based on Negative Pressure Steam Purging Circulation. This invention was developed by Zhang Bingshan, Wang Lu, Joo Hyun Chan and Xu Yifei. The patent application number is CN20251220851 20251230. The pat..

Hebei Wanbang Folon Pharmaceutical Applies for Patent on Method for Reducing Ash Content of Indigo Naturalis

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Hebei Wanbang Folon Pharmaceutical has applied Chinese patent for Method for Reducing Ash Content of Indigo Naturalis. Jian Qiufang, Ge Yue, Zhang Xiabing and Liu Guolin developed it. The patent application number is CN202511899344 20251216. The patent publication number is CN121550741 (A). International Pat..

State Intellectual Property Office of China Releases Nanfang Hospital, Southern Medical University Patent Application for Intelligent Breathing Training Device for Old Patients wit..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has released Nanfang Hospital, Southern Medical University patent application for Intelligent Breathing Training Device for Old Patients with Chronic Obstructive Pulmonary Disease. This invention was developed by Huang Zhaohui. The patent application number is CN20..

State Intellectual Property Office of China Publishes Kunshan Yingkai Precision Plastic Patent Application for Eye Therapeutic Apparatus

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has published Kunshan Yingkai Precision Plastic patent application for Eye Therapeutic Apparatus. The invention was developed by Yu Min, Jiang Guoqiang and Zhang Wenyuan. The patent application number is CN20251211628 20251229. The patent publication number is CN12..

Nanjing Congjing Biotechnology Submits Chinese Patent Application for Ultrashort Wave Therapeutic Apparatus Capable of Lifting and Overturning

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Nanjing Congjing Biotechnology has submitted a patent application for Ultrashort Wave Therapeutic Apparatus Capable of Lifting and Overturning. This invention was developed by Wan Jingran and Zhou Liang. The patent application number is CN202511831235 20251207. The patent publication number is CN121550589 (A..

State Intellectual Property Office of China Releases Shenzhen Third People's Hospital Shenzhen Liver Disease Research Institute Patent Application for Traditional Chinese Medicine ..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has released Shenzhen Third People's Hospital Shenzhen Liver Disease Research Institute patent application for Traditional Chinese Medicine Infrared Therapeutic Instrument. This invention was developed by Cai Kanru, Chen Chaowu, Chao Hua and Zheng Baoqi. The patent..

Henan Psychiatric Hospital the Second Affiliated Hospital of Xinxiang Medical University Submits Patent Application for Method for Treating Chronic Insomnia by Percutaneous Magneti..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Henan Psychiatric Hospital the Second Affiliated Hospital of Xinxiang Medical University has submitted a patent application for Method for Treating Chronic Insomnia by Percutaneous Magnetic Stimulation of Stellate Ganglion Block. Zhang Xiaoyang, Wang Haiqiang, Xu Pengjiao, Zhang Ruiling, He Rongjie, Xu Yahui,..

State Intellectual Property Office of China Publishes Ganzhou Third People's Hospital Patent Application for Sleep Therapeutic Apparatus Output Current Intelligent Control Circuit

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has published Ganzhou Third People's Hospital patent application for Sleep Therapeutic Apparatus Output Current Intelligent Control Circuit. The invention was developed by Cai Wenting and Chen Lijuan. The patent application number is CN202511753174 20251126. The pa..

Wenzhou People's Hospital Submits Chinese Patent Application for Microneedle Transdermal Drug Delivery Device

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Wenzhou People's Hospital has submitted a patent application for Microneedle Transdermal Drug Delivery Device. This invention was developed by Yang Jinzhao, Zeng Guowu and Wu Yu. The patent application number is CN20251250306 20251231. The patent publication number is CN121550566 (A). International Patent Cl..

State Intellectual Property Office of China Receives China Japan Friendship Hospital China Japan Friendship Institute of Clinical Medicine Patent Application for Drug Inhalation Do..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has received China Japan Friendship Hospital China Japan Friendship Institute of Clinical Medicine patent application for Drug Inhalation Dosage Intelligent Control Method and System Based on Drug Inhalation Equipment. Huang Ke, Yang Ting and Ren Xiaoxia developed t..

Beijing Kangerfu Pharmaceutical Submits Chinese Patent Application for Naoxuekang Dropping Pill Placebo as Well as Preparation Method and Application Thereof

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Beijing Kangerfu Pharmaceutical has submitted a patent application for Naoxuekang Dropping Pill Placebo as Well as Preparation Method and Application Thereof. This invention was developed by Song Xintong, Wen Dongyan, Xu Yingzhi, Sun Liwen, Shen Zheng, Cao Kegang, Zhang Qian, Du Boxuan and Song Mingxuan. The..

Nanjing Drum Tower Hospital Applies for Patent on Application of WWP1 in Preparation of Medicine for Preventing and/or Treating Aortic Dissection

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Nanjing Drum Tower Hospital has applied Chinese patent for Application of WWP1 in Preparation of Medicine for Preventing and/or Treating Aortic Dissection. Zhou Qing, Kong Chuiyu and Chen Xing developed it. The patent application number is CN202511835812 20251208. The patent publication number is CN1215504..

Jewim Pharmaceutical (Shandong) Applies for Patent on Preparation Method of Mianserin Sulfate

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Jewim Pharmaceutical (Shandong) has applied Chinese patent for Preparation Method of Mianserin Sulfate. Wang Xianglei, Yin Miaolin, Sun Yingji, Li Gang, Li Tiejun and Guo Xiao developed it. The patent application number is CN202511709040 20251120. The patent publication number is CN121554474 (A). Internation..

Jewim Pharmaceutical (Shandong) Submits Chinese Patent Application for Preparation Method of Trospium Chloride

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Jewim Pharmaceutical (Shandong) has submitted a patent application for Preparation Method of Trospium Chloride. This invention was developed by Lu Hui, Sun Yingji, Cao Xueli, Li Tiejun, Wang Jianqiang and Guo Xiao. The patent application number is CN202511710790 20251120. The patent publication number is CN1..

Southeast University Seeks Patent for Targeted Coupling Small Molecule and Preparation Method, Pharmaceutical Composition and Application Thereof

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Southeast University has sought patent for Targeted Coupling Small Molecule and Preparation Method, Pharmaceutical Composition and Application Thereof. This invention was developed by Cai Libo and Gou Shaohua. The patent application number is CN202511748511 20251126. The patent publication number is CN121554..

The Second Hospital of Anhui Medical University Submits Chinese Patent Application for Aromatic Acylhydrazone Compound, Pharmaceutical Composition and Application

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- The Second Hospital of Anhui Medical University has submitted a patent application for Aromatic Acylhydrazone Compound, Pharmaceutical Composition and Application. This invention was developed by Yao Feng, Zhao Yingjie, Zhou Renpeng, Hu Wei, Wei Xin and Lu Chao. The patent application number is CN20251169233..

State Intellectual Property Office of China Receives University Yunnan Traditional Chinese Medicine Patent Application for Ploretin-trilobatin Co-amorphous Substance and Solid Disp..

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- State Intellectual Property Office of China has received University Yunnan Traditional Chinese Medicine patent application for Ploretin-trilobatin Co-amorphous Substance and Solid Dispersion Thereof, and Preparation Method and Pharmaceutical Application Thereof. Hou Anguo, Ding Xiong, Tan Qiuru, Wang Wenping,..

Shandong Guohetang Pharmaceutical Submits Chinese Patent Application for Full-automatic Fermentation Device for Producing Active Probiotics

Pharmaceutical

| Fri 19 Jun 2026

Beijing, June 19 -- Shandong Guohetang Pharmaceutical has submitted a patent application for Full-automatic Fermentation Device for Producing Active Probiotics. This invention was developed by Zhao Yankui and Xun Yuzhi. The patent application number is CN202511905712 20251217. The patent publication number is CN121555304 (A). I..

Laekna Therapeutics, Shanghai Files WIPO Patent Application for Methods of Treating Overweight and/or Obesity with Anti-ACVR2A Antibodies

Pharmaceutical

| Fri 19 Jun 2026

Geneva, June 19 -- Laekna Therapeutics, Shanghai has filed a patent application for Methods of Treating Overweight and/or Obesity with Anti-ACVR2A Antibodies. This invention was developed by Lu Chris Xiangyang, Gu Xiang-ju Justin, Zhang Ruipeng, Wang Jun and Alvarez-diez Teresa. The patent application number is WO2024CN136122..

World Intellectual Property Organization Receives West China Hospital, Sichuan University Patent Application for HDAC6 Inhibitor, Pharmaceutical Composition, and Use

Pharmaceutical

| Fri 19 Jun 2026

Geneva, June 19 -- World Intellectual Property Organization has received West China Hospital, Sichuan University patent application for HDAC6 Inhibitor, Pharmaceutical Composition, and Use. Bai Ping developed the invention. The patent application number is WO2025CN109422 20250718. The patent publication number is WO2026118474..

Shenyang Xingqi Pharmaceutical Submits WIPO Patent Application for Human Nerve Growth Factor Pharmaceutical Composition and Use Thereof

Pharmaceutical

| Fri 19 Jun 2026

Geneva, June 19 -- Shenyang Xingqi Pharmaceutical has submitted a patent application for Human Nerve Growth Factor Pharmaceutical Composition and Use Thereof. This invention was developed by Jin Yang, Yang Qiang, Li Xiaowen, Liu Jidong and Li Li. The patent application number is WO2025CN138425 20251128. The patent publication n..

Tennor Therapeutics (Suzhou) Submits WIPO Patent Application for Compound and Use Thereof

Pharmaceutical

| Fri 19 Jun 2026

Geneva, June 19 -- Tennor Therapeutics (Suzhou) has submitted a patent application for Compound and Use Thereof. This invention was developed by Xue Xiaojian, He Shijie, Zhuang Zhijun, Sun Jing, Zhang Ling, Lu Siqi, Ma Zhenkun and Guan Xiaotian. The patent application number is WO2025CN139045 20251201. The patent publication nu..

World Intellectual Property Organization Publishes Jiangsu Hengrui Pharmaceuticals Patent Application for Preparation Method for and Use of Oxetane Derivative or Salt Thereof

Pharmaceutical

| Fri 19 Jun 2026

Geneva, June 19 -- World Intellectual Property Organization has published Jiangsu Hengrui Pharmaceuticals patent application for Preparation Method for and Use of Oxetane Derivative or Salt Thereof. The invention was developed by Jiang Wei, Cao Weicou, Luo Guangshun, Zhao Fuqiang, Huang Jian and He Shebin. The patent applicatio..

World Intellectual Property Organization Publishes Changchun Genescience Pharmaceutical Patent Application for Piperidinedione Compound, Preparation Method Therefor, Pharmaceutical..

Pharmaceutical

| Fri 19 Jun 2026

Geneva, June 19 -- World Intellectual Property Organization has published Changchun Genescience Pharmaceutical patent application for Piperidinedione Compound, Preparation Method Therefor, Pharmaceutical Composition Comprising Compound, and Use Thereof. The invention was developed by Zhang Chen, Liu Meng, Yang Fanglong, Lu Biao,..

1 to 100 of 1989 Items Next >>

Home
|
About Us
|
Privacy Policy
|
Support
|
Products
|
Careers
|
Contact Us

© Copyright 2015. All Right Reserved.

Email selected articles